Indication
Rabies Vaccine Adverse Reaction
2 clinical trials
5 products
Clinical trial
Randomized, Blind, Phase III Clinical Trial Comparing the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (MRC-5 Cells) With a 5-dose Program and a 4-dose (2-dose First-dose) ProgramStatus: Completed, Estimated PCD: 2021-07-21
Clinical trial
A Randomized, Blinded, and Similar Vaccine-controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of the 5-dose Program and 4-dose (2-1-1) Program of Freeze-dried Human Rabies Vaccine (Vero Cells)Status: Active (not recruiting), Estimated PCD: 2024-09-30